MSACL 

MSACL 2011

3rd Annual Conference

Session Program: SHORT Abstracts (2.5MB PDF) | Session Program: LONG Abstracts (12MB PDF)

Submitted Abstracts: 245

Feb 5-9, 2011

** FINAL SCHEDULE **

Posters | Exhibits

Saturday Feb 5
7:00 AM BREAKFAST (provided)
Short Courses
9AM - 4PM Two Day Fundamental LC-MS/MS and Methods Development
Lead: Jack Henion
Development and Validation of Quantitative LC-MS/MS Assays for Use in Clinical Diagnostics
Lead: Russ Grant
One Day Introduction to Mass Spectrometry
Lead: Robert Kobelski
LUNCH provided between 11:30am and 1:30pm
Exact break time is at the discretion of instructor.

Sunday Feb 6
7:00 AM BREAKFAST (provided)
Short Courses
9am - 4pm Two Day Fundamental LC-MS/MS and Methods Development
Lead: Jack Henion
Development and Validation of Quantitative LC-MS/MS Assays for Use in Clinical Diagnostics
Lead: Russ Grant
One Day Chromatographic Applications
for Mass Spectrometry

Lead: Brian Crow
with Megan McGuigan
Metabolomics
Lead: Gary Siuzdak
with Gary Patti
Proteomics
Lead: Andy Hoofnagle
with Mike MacCoss,
Nathan Yates
LUNCH provided between 11:30am and 1:30pm
Exact break time is at the discretion of instructor
Opening of General Scientific Session
3:00 PM

OPENING RECEPTION IN EXHIBIT HALL

with Super Bowl XLV Coverage

Sunday Evening Plenary Session
Chair: Russ Grant
7:30 PM
The Promise Of The Cacao Flavanol (-)-Epicatechin As A Therapeutic Agent
Francisco Villarreal
University of California, San Diego

Confirmed
8:30 PM Hospitality Suite
Outdoor Heated Patio Overlooking San Diego Marina

Monday Feb 7
7:00 AM BREAKFAST (provided)
8:00 AM Opening Remarks and Welcome
David Herold
VA Healthcare San Diego and University of California, San Diego
Monday Morning Plenary Session
Chair: David Herold
8:10 AM Innovative Mass Spectrometry Technology for the Identification of Cancer Immunotherapeutics
Donald F. Hunt
University of Virginia

Confirmed
9:10 AM Micro-Algae for the Production of Biofuels and Bio-Products
Stephen Mayfield
San Diego Center for Algae Biotechnology, UCSD

Confirmed
10:00 AM COFFEE BREAK

Small Molecule Analysis
Chair: Brett Holmquist

Track 1

Applied Metabolomics
Chair: Gary Siuzdak

Track 2

Chemical Warfare Agents
Chair: Ben Blount

Track 3

10:30 AM Steroid Analysis in Clinical Diagnostics: Selectivity, Sensitivity and Speed
Russell Grant
LabCorp, Inc.

Confirmed
Building a Sustainable Biomarker Pipeline by Comprehensive Metabolite Profiling
Volker Liebenberg
Metanomics Health

Confirmed
Biomarker Analysis for Verification of Chemical Warfare Agent Exposure in Humans and Animal Models
Benedict R. Capacio
US Army

Confirmed
11:00 AM Development of an LC-MS/MS Method for 1,25-Dihydroxyvitamin D for Use in the Clinical Laboratory
Frederick G. Strathmann
University of Washington

Confirmed
The Metabolomic Landscape of Chemotherapy Resistance
Anders Nordstrom
Karolinska Institute, Sweden

Confirmed
An Improved Procedure for the Rapid Analysis of Lewisite Metabolites in Urine by LC-ICP-MS
Stephen Donovan
Pennsylvania Department of Health

Confirmed
11:30 AM Developing and Validating a LC-MS/MS Method for Concurrently Measuring Cortisol, 11-Deoxycortisol, DHEA, Androstenedione, Progesterone and 17-Hydroxyprogesterone: Challenges and Possible Applications
Victor Goh
UCLA at Harbor

Confirmed
Metabolomics of Bacterial Infection
Gary Patti
The Scripps Research Institute

Confirmed
Development of a Quantitative, High Throughput OP-Nerve Agent Adduct Method
Jennifer Sporty
CDC

Confirmed
PosterSplash
Small Molecule Analysis
Poster Splash
Metabolomics
Poster Splash
Various
12:00 PM
1. Interferences in an LC-MS/MS Steroid Assay: Systematic Reduction of Possible Endogenous Interferences from Database Searches and Examination of an Exogenous Interference from Sample Collection
Jason Cournoyer
PerkinElmer Life Sciences

Confirmed
11. An LC-MS-based Metabolomics Approach for the Development of Diagnostic Tools for Onchocerciasis
Judith Denery
The Scripps Research Institute

Confirmed
21. The Effect of Temperature and Storage Duration on the Stability of Environmental Contaminants Metabolites
Paramjit Behniwal
California Department of Public Health

Confirmed
12:06 PM
3. Quantitative Analysis of Underivatized 1,25-Dihydroxyvitamin D3 and D2 in Blood by UHPLC and Triple Quadrupole Mass Spectrometer Utilizing Ion Funnels Technology
Andre Szczesniewski
Agilent Technologies, Inc.

Confirmed
13. Search for Colon-derived Uremic Toxins in Humans Using an Orbitrap-based Metabolomics Platform
Pavel A. Aronov
Stanford University

Confirmed
23. Ultra High Resolution Mass Spectrometric Determination of the Marine Toxins, Azaspiracids, in Plasma
Zuzana Skrabakova
PROTEOBIO

Confirmed
12:12 PM
5. Method Optimization for High-Throughput 25-OH Vitamin D Analysis: The Devil is in the Details
Julia Drees
Kaiser Permanente

Confirmed
15. Metabolomics: A Tool for Early Detection of Toxicological Effects and an Opportunity for Biology-based Grouping of Chemicals
Hajo Schiewe
Metanomics Health / BASF SE

Confirmed
25. An Investigation of Deuterium Scrambling in Stable-Labeled Internal Standards during LC-MS/MS Analysis
Derrell Johnson
Cerilliant Corporation

Confirmed
12:18 PM
7. Simple and Rapid Sample Preparation for 25OH-VitaminD3/D2 using an Immobilized Liquid
Christiane Zaborosch
Zuerich University of Applied Sciences, Switzerland

Confirmed
17. Targeted Lipidomics: High-Throughput Quantitation of Several Hundreds of Lipid Metabolites in Plasma Samples via Flow-Injection ESI-MS/MS
Diane Schmiederer
Biocrates Life Sciences AG

Confirmed
27. Development of a Synthetic Protein Quality Control (QC) Standard for the Assessment of Sample Proteolysis Reproducibility
Bryan Krastins
ThermoFisher Scientific

Confirmed
12:24 PM
9. Measurement of 25-Hydroxyvitamin D3 and C3-Epi-25-hydroxyvitamin D3 using UPLC-MS/MS in the Adult Population
Lisa Calton
Waters Corporation

Confirmed
19. Metabolomic Fingerprinting of Three Strains of Rat using Ultra High Resolution Time-of-Flight Mass Spectrometry -- Qualitative and Semi-Quantitative Comparison of Fat, Diabetic and Control Zucker Rats
Jeffrey S. Patrick
Leco Corporation

Confirmed
29.Determination of Dialkyl Phosphate Metabolites of Organophosphate Pesticides in Human Urine by Gas Chromatography/High Resolution Mass Spectrometry
Dongli Wang
California Department of Public Health

Confirmed
12:30 PM
LUNCH (provided)
Pick it up before attending a workshop.
LUNCH & LEARN: Industrial Workshops
12:45 - 1:45 PM
Improving Confidence and Productivity in Endocrine and Pain Management Drug Assays
Thermo Scientific - Register
Track 1: Harbor Ballroom
Improving Measurement of Protein Biomarkers by Mass Spectrometry: Methods and Workflows
&
Quantitative Analysis of Underivatized 1,25-Dihydroxyvitamin D3 and D2 in Blood by UHPLC and Triple Quadrupole Mass Spectrometer Utilizing Ion Funnel Technology

Agilent Technologies - Register
Track 2: Harbor Ballroom
Meeting the Challenge: LC-MS/MS Solutions for the Clinical Research Laboratory
AB SCIEX - Register
Track 3: Harbor Ballroom
30 Years of Steroid Analysis: From RIA to Turboflow LC-MSMS
PerkinElmer
Executive 1
Truth in Measurement – LC/MS/MS in the Clinical Laboratory
Waters - Register
Executive 2
Novel Diagnostic Kits for LC-MS/MS: From Research to Daily Routine Analysis
ChromSystems
Executive 3
EXHIBITS & POSTERS
in the Exhibit Hall
Testosterone Measurement By Mass Spectrometry
Chair: Shalender Bhasin



Track 1

How Patents, the FDA, and Multiplexed Assays are Changing Clinical Mass Spectrometry
Chair: Steve Master

Track 2

Microbiology
Chair: Yi-Wei Tang




Track 3

3:00 PM Population-Based Reference Ranges for Testosterone in Men
Shalender Bhasin
Boston University

Confirmed
Combining Multiple Biomarkers - More is Usually Better - Up to a Point
Steve Skates
Massachusetts General Hospital

Confirmed
Mass Spectrometry Biotyper System Identifies Enteric Bacterial Pathogens Directly from Colonies Grown on Selective Stool Culture Media
Yi-Wei Tang
Vanderbilt University

Confirmed
3:30 PM CDC Testosterone Standardization Project - A Progress Report
Hubert Vesper
CDC

Confirmed
Are Multiplex Assays Approvable? Considerations for Obtaining FDA Clearance or Approval on Multi-Marker Tests
Mya Thomae
Myraqa, Inc.

Confirmed
Characterizing the Adaptation of P. aeruginosa to the Cystic Fibrosis Lung Using GCxGC-TOF and SESI-MS
Heather D. Bean
University of Vermont

Confirmed
4:00 PM Clinical Testosterone Analysis for the Masses: Taking Testosterone Testing to the Next Level
Matthew Crawford
LabCorp

Confirmed
Keeping Multiplex Assays in Control
Stephen R. Master
University of Pennsylvania

Confirmed
A PCR-ESI/Mass Spectrometry Solution for Detection and Identification of Unculturable Pathogens
Mark Eshoo
Ibis Biosciences

Confirmed
Poster Splash
Small Molecule
Poster Splash
Biomarkers
Poster Splash
Microbiology
4:30 PM
2. Sensitive and Specific Quantitation of 1α, 25-Dihydroxy Vitamin D3 and Analogs using LC-MS/MS and Labeling Chemistry
Subhakar Dey
AB SCIEX

Confirmed
12. Development of Human Serum N-Glycan Library for Rapid Identification in Disease Biomarker Discovery Using nanoLC-MS
Danielle Aldredge
University of California, Davis

Confirmed
22. Generating a Library of Human Microbiome-derived Microorganisms to Discover Novel Natural Products
Matthew Hamby
UCSD

Confirmed
04:36 PM
4. The Analysis of Testosterone by LC-MS/MS: A Comparison to Immunoassay
John McFarlane
AB SCIEX

Confirmed
14. Comparative Analysis of Serum and Tissue Samples from Cervical Cancer Patients for Biomarker Discovery
Natalia Govorukhina
University Groningen

Confirmed
24. Mass Spectrometry-based MALDI Biotyper System for Rapid and Reliable Yeast Species Identification Directly from Positive Blood Culture Media
Yingjun Yan
Vanderbilt University

Confirmed
04:42 PM
6. Prototype ARCHITECT® 2nd Generation Testosterone Immunoassay Compared to LC-MS/MS
Stuart Blincko
Abbott Diagnostics

Confirmed
16. Quantitative Analysis of Hepcidin in Biofluids and its Role in Diagnosis and Monitoring of Hemochromatosis and Anaemia
Ian Mullaney
School of Pharmacy, Murdoch University

Confirmed
26. Rapid Detection of Salmonella by Selective Enrichment and Mass Spectrometry-Based MALDI Biotyper
Markus Kostrzewa
Bruker Daltonik, GmbH

Confirmed
04:48 PM
8. Quantitative Analysis of Steroids in Blood by Simultaneous Positive and Negative Ionization using QQQ LC-MS/MS
Yanan Yang
Agilent Technologies, Inc.

Confirmed
18. Development and Validation of an LC-MS/MS Assay for Quantitation of Plasma Asymmetric Dimethylarginine (ADMA), Symmetric Dimethylarginine (SDMA), and Arginine
Alan Lueke
Mayo Clinic Rochester

Confirmed
28. Characterization of a Molecular-Based Assay System (PLEX-ID) for Broad Range Detection of Bacteria, Candida, and Antibiotic Resistance from Blood Culture Bottles
Lawrence Blyn
Ibis Biosciences

Confirmed
04:54 PM
10. LC-MS/MS for Quantification of Total Testosterone in Serum
Heng Shi
Children's Hospital of Philadelphia

Confirmed
20. Assessment of Proteomic Changes in the Rat Brain following 17 beta-estradiol Treatment of Hemorrhagic Shock
Kyoko Kojima
University of Alabama at Birmingham

Confirmed
30. Mass Spectrometry-based Analytical Methods for Adeno-associated Virus (AAV) Gene Therapy Vectors
Kim Van Vliet
University of Florida

Confirmed
5:00 PM RECEPTION IN EXHIBIT HALL / POSTERS
Monday Evening Plenary Session
Chair: Russ Grant
7:30 PM Mass Spectrometry-Based Metabolomics as a Unique Biochemical Approach for Therapeutic Discovery
Gary Siuzdak
The Scripps Research Institute

Confirmed
8:30 PM Hospitality Suite
Outdoor Heated Patio Overlooking San Diego Marina

Tuesday Feb 8
7:00 AM BREAKFAST (provided)
Tuesday Morning Plenary Session
Chair: Gary Siuzdak
8:00 AM Mass Spectrometry: Chemistry's Toolset for the 20th Century, Biology's Toolset for the 21st
Bruce German
University of California, Davis

Confirmed
9:00 AM Should Limitations be Placed on Ownership of Personal Medicine Discoveries? Should Personalized Treatment for an Individual's Genetic or Metabolic Makeup be Classified Differently?
Anthony G. Craig
Sci-Law Strategies, PC

Confirmed
10:00 AM COFFEE BREAK
Clinical Toxicology & TDM:
State of the Art

Chair: Jim Ritchie

Track 1

Discovery Proteomics
Chair: Jeff Whiteaker


Track 2

Regulations and Standards
Chair: Hubert Vesper


Track 3

10:30 AM Synthetic Cannabinoids- Identification, Detection, and Quantitation in Blood, Urine and Oral Fluid by LC-MS/MS
Matthew McMullin
NMS Labs

Confirmed
Determination of Protein Turnover in Infants Diagnosed with Respiratory Distress Syndrome using Liquid Chromatography-Selected Reaction Monitoring-Mass Spectrometry
Mike MacCoss
University of Washington

Confirmed
FDA Oversight of Laboratory Developed Tests (LDTs): Where are we and where are we going?
Katherine Serrano
Food and Drug Administration

Confirmed
11:00 AM General Unknown Screening Using ToF-MS: A Reference Lab Perspective
Kevin Shanks
AIT Laboratories

Confirmed
Biomarker Discovery in Stroke Samples Using a Quantitative, Two-Pass LC-MS/MS Workflow Incorporating ROC Curve Analysis
Mary Lopez
BRIMS

Confirmed
A Mass Spec Method Does Not Necessarily a Reference Method Make – the Role of the Joint Committee for Traceability in Laboratory Medicine
Mary M. Kimberly
CDC

Confirmed
11:30 AM Development of UPLC-LC-MS/MS Assays for the Newer Antidepressants, Antipsychotics, and their Active Metabolites
James C. Ritchie
Emory University

Confirmed
Building Multidimensional Biomarker Views of Type 2 Diabetes and Comorbidities Based on Protein Microheterogeneity
Randall W. Nelson
The Biodesign Institute at Arizona State University

Confirmed
Clinical and Laboratory Standards Institute (CLSI) Standards and Guidelines Development: Process and Clinical Applications
Barbara Goldsmith
Clinical and Laboratory Standards Institute

Confirmed
PosterSplash
Clinical Toxicology
Poster Splash
Proteomics
Poster Splash
New Advances
12:00 PM
1. LC-MS/MS Analysis of Opioids in Urine – Significance of Glucuronide Metabolites
Deborah French
University of California, San Francisco

Confirmed
11. A High-Throughput Mass Spectrometric Immunoassay for Intact Insulin, Insulin Metabolites, Synthetic Insulins, C-peptide, and C-peptide Metabolites for Population Proteomics Studies
Paul Oran
The Biodesign Institute at Arizona State University

Confirmed
21. Mapping the Activity of Oncogenic Signaling Networks in FFPE Tissue with Phospho-Specific Liquid Tissue® Mass Spectrometry
Todd Hembrough
Expression Pathology, Inc.

Confirmed
12:06 PM
3. Antifungal Azole Panel by 2D-LC-MS/MS
Bingfang Yue
ARUP

Confirmed
13. Improvements in Peptide MRM Sensitivity Using Multiplex Monoclonal Antibody Capture (SISCAPA) and an Ion Funnel QQQ-MS at Standard Flow Rate
N. Leigh Anderson
Anderson Forschung Group

Confirmed
23. Ultra Performance Mass Spectrometry without Comprise: High Resolving Power Multi-reflecting Time-of-Flight Technology with High Speed Data Acquisition
John A. Chakel
LECO Corporation

Confirmed
12:12 PM
5. LC-MS/MS Observations on the Metabolic Ratio of Oxycodone to Oxymorphone in Urine Samples from Pain Patients
David A. Yee
University of California, San Diego

Confirmed
15. Human Osteocalcin Characterization by Mass Spectrometric Immunoassay (MSIA)
Douglas S. Rehder
The Biodesign Institute at Arizona State University

Confirmed
25.

12:18 PM
7. Automated Toxicology Screening of Biological Specimens Using Deconvolution Reporting Software and GC-MS Instrumentation
Alex L. Maggitti, III
NMS Labs

Confirmed
17. Combined Use of Immunoassay and 2-D LC/MS for the Detection and Identification of Metabolites From Biotherapeutic Pharmacokinetic Samples
Robert Murphy
CovX, Pfizer Biotherapeutics R&D

Confirmed
27. Optimization of Rapid Heavy Metals Blood Analysis for Ultra Low Detection Limits by ICP-MS with ISIS
Ryszard Gajek
California Department of Public Health

Confirmed
12:24 PM
9. An Automated Ion Trap MS-based Screening Solution for Clinical and Forensic Toxicology (Still presenting as a poster, but NO SPLASH)
Gary Kruppa
Bruker Daltonik, GmbH

Confirmed
19. Layered Electrophoretic Transfer – A Method for Pre-Analytic Processing of Histological Sections
Liang Zhu
National Institutes of Health

Confirmed
29. 3-Epi-25-OH-Vitamin D3 in Infants
Daniel Fabian
Viollier AG Spezialanalysen

Confirmed
12:30 PM
LUNCH (provided)
Pick it up before attending a workshop.
LUNCH & LEARN: Industrial Workshops
12:45 - 1:45 PM
Use of Trainer Peptides to Increase the Reproducibility and Robustness of SRM-Based Assays for Clinical Proteomics Research
Thermo Scientific - Register
Track 1: Harbor Ballroom
Nuances of Mass Spectrometry Method Validation
PerkinElmer
Track 2: Harbor Ballroom
Tools to Accelerate Toxicology Workflows
AB SCIEX - Register
Track 3: Harbor Ballroom
Clinical Research Applications of MALDI-TOF Mass Spectrometry: Sepsityper for Rapid ID of Microorganisms from Positive Blood Culture; MALDI Molecular Imaging for Biomarker Discovery and Drug Imaging
Bruker
Executive 1
Quantitative Reversed Phase LC/MS/MS Analysis of Ethyl Glucuronide and Ethyl Sulfate from Urine
&
A Multiplexed Method for the Determination of Androgens in Serum and Plasma by HPLC-MS/MS

Phenomenex
Executive 2
Pressure Cycling Technology (PCT): Next Generation Platform for the Preparation of Biomolecules for Mass Spectrometry Analysis
Pressure Biosciences
Executive 3

EXHIBITS & POSTERS
in the Exhibit Hall

New Advances
Chair: Jack Henion


Track 1

Tissue Analysis
Chair: Gary Patti


Track 2

Metabolic and Newborn Screening
Chair: Don Chace

Track 3

3:00 PM TBD
Michael Roukes
California Institute of Technology

Confirmed
Mass Spectrometry Tools and Methods Towards Intra-Operative Decision-Making
Justin M. Wiseman
Prosolia

Confirmed
The Dried-Blood Spot Shop: CDC’s Role in Assuring Quality of Dried-Blood Spot Assays Worldwide
Victor DeJesus
CDC

Confirmed
3:30 PM Mass Spectrometry Solution to the Multi-parameter Flow Cytometry Challenge
Scott Tanner
University of Toronto

Confirmed
Quantitative Analysis of Growth Factor Receptors and Pathway Activation in FFPE Tumor Tissue
REPLACING
(Alterations of Striatal Dynorphin Peptide Levels in L-DOPA Induced Dyskinesia Revealed by Imaging Mass Spectrometry
WITHDRAWN)

Todd Hembrough
Expression Pathology, Inc.

Confirmed
Performance Evaluation Study of a Second-Tier CAH Newborn Screening Method Utilizing Steroid Profiling by LC-MS/MS
Mark Fountain (in place of Patricia Hunt)
Texas Department of State Health Services

Confirmed
4:00 PM Automated Liquid Extraction Surface Analysis (LESA) Combined with nano Electrospray Tandem Mass Spectrometry as a Novel Tool for Analyzing Surfaces
Jack Henion
Advion BioSciences, Inc.

Confirmed
A Library of 7000 SRM Assays for the Fast, Sensitive and Reproducible Quantification of N-Glycosites in Tissue and Plasma Samples: The N-Glycosite SRM Atlas
Bernd Wollscheid
Institute of Molecular Systems Biology, ETH Zurich

Confirmed
The Dried "X" Spot: A Keystone Supporting Mass Spectrometry Based Clinical Assays in Metabolic and Newborn Screening
Donald Chace
Pediatrix Analytical

Confirmed
PosterSplash
New Advances
Poster Splash
Various
Poster Splash
InBorn Errors in Metabolism
4:30 PM
2. Increasing LC-MS Assay Robustness Through Increased Specificity Using High Resolution MRM-like Analysis
Christie Hunter
AB SCIEX

Confirmed
12. Global Phosphoproteomics of Transforming Growth Factor β Stimulated PANC-1 Cells
Hyonson Hwang
Translational Genomics Research Institute

Confirmed
22. Evaluation of Selected Short Chain Acylcarnitines in Blood Spots, Plasma and Urine by UPLC-MS/MS for the Differential Diagnosis of Branched-chain Organic Acidurias
Aiping Liu
ARUP Institute for Clinical and Experimental Pathology

Confirmed
4:36 PM
4. Fully Automated Analysis of PCR Products by High Performance ESI-TOF Mass Spectrometry: A Novel Platform for Clinical Research
Jose R. Gutierrez
Ibis Biosciences

Confirmed
14. α-Galactosidase A (GLA) Activity for Fabry Disease Screening by : Inexpensive, Fast Sample Preparation
Sabrina Forni
Baylor Research Institute

Confirmed
24. Characterization of Plasma and Urine Metabolites in Barth Syndrome Patients Employing LC-MS/MS and GC-MS Strategies
Yana Sandlers
Kennedy Krieger Institute

Confirmed
4:42 PM
6. Mass Spectrometric Immunoassays for Quantitative Determination of Protein Biomarker Isoforms
Olgica Trencevska
Intrinsic Bioprobes

Confirmed
16. Liquid Extraction of Endocannabinoids with Toluene Reduces Matrix Effect and Trans-acylation of 2-Arachidonoyl Glycerol to 1-Arachadinoyl Glycerol
Alexander A. Zoerner
Hannover Medical School, Germany

Confirmed
26. High-Throughput Quantification of Acylcarnitines in Biological Samples by UHPLC MS/MS
Azeret Zuniga
University of Alberta

Confirmed
4:48 PM
8. A Nanotechnology-based Biomarker Strategy for Discovery and Detection
Brian Feild
Shimadzu Scientific Instruments

Confirmed
18. The Utility of Serum LC-MS/TOF Targeted and Non-Targeted Drug and Drug Metabolite Analysis in Solving Poison Control Center Cases
Roy Gerona
University of California, San Francisco

Confirmed
28. Simplified High-Throughput Multiplexed, Multi-Dimensional UHPLC-MS/MS Assay for the Screening Of Lysosomal Storage Disorders in Newborn Dried Blood Spots
David Kasper
Medical University of Vienna

Confirmed
4:54 PM
10. Improving the Efficiency and Throughput of an Enzymatic Digestion of Klotho using Pressure Cycling Technology (PCT)
Taha Rezai
ThermoFisher Scientific

Confirmed
20. Relationship Between the Concentration of Hydrocodone and its Conversion to Hydromorphone in Chronic Pain Patients using LC-MS/MS Urinary Excretion Data
Neveen Barakat
University of California, San Diego

Confirmed
30. Quantification of 7alpha-Hydroxy-4-cholesten-3-one, a Disease Marker for Cerebrotendinous Xanthomatosis, in Human Plasma using Novel Derivatization Chemistry and LC-MS/MS
Andrea DeBarber
Oregon Health & Science University

Confirmed
5:00 PM RECEPTION IN EXHIBIT HALL / POSTERS
7:30 PM
Tuesday Evening Workshops
MSACL 2012 Organizing Committee
Chair: David Herold
Inborn Errors of Metabolism
Chair: Don Chace
Regulations and Standards
Chair: Hubert Vesper
Proteins, Proteomics and Disease Markers
Chair: Mike MacCoss
Small Molecule, Tox, Environmental
Chair: Russ Grant
Tissue Analysis by Mass Spec
Chair: Jon Burrows
Metabolomics
Chair: Gary Patti
Public Involvement of Scientists in PEER to PATENT Project to Improve Patent Quality
Chair: Anthony Craig
8:30 PM Hospitality Suite
Outdoor Heated Patio Overlooking San Diego Marina

Wednesday Feb 9
7:00 AM BREAKFAST (provided)
Toxicology
Chair: Rob Fitgerald

Track 1

Targeted Proteomics
Chair: Nathan Yates

Track 2

Novel Approaches to Mass Spectrometry-Based Clinical Measurements
Chair: John Barr

Track 3

8:00 AM LC-MS/MS Unknown Screening in a Large-Scale Forensic Toxicology Study: Enlighten the Needle in the Haystack?
Pierre-Alain Binz
Geneva Bioinformatics

Confirmed
Evaluation of Multiplexing Capabilities Using Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry for Quantitation of Peptides
Jeff Whiteaker
Fred Hutchinson Cancer Research Center

Confirmed
Detection, Differentiation, Quantification and Subtyping of Botulinum Neurotoxins in Clinical Samples with Mass Spectrometry
John Barr
CDC

Confirmed
8:30 AM Simultaneous Multi-Targeted and Unknown Screening of Urine Samples by LC-MS/MS with Automated Library Searching for Compound Identification
Michael Jarvis
AB Sciex

Confirmed
Enhanced Sensitivity of MRM-based Protein Quantitation in Plasma
Christoph Borchers
University of Victoria

Confirmed
Intact Protein Quantification by Mass Spectrometry
Mark W. Duncan
University of Colorado, Denver

Confirmed
9:00 AM Utilizing LC-MS/TOF to Identify Designer Drugs in the Clinical Laboratory
Matt Petrie
University of California, San Franciso

Confirmed
Quantitative Analysis of IGF-1 by High Resolution Mass Spectrometry
Cory Bystrom
Quest Diagnostics Nichols Institute

Confirmed
Strategies for Bacterial Identification Using Bacteriophage Amplification Detection Coupled with Mass Spectrometry
Carrie Pierce
Georgia Institute of Technology/CDC

Confirmed
9:30 AM Dilute and Shoot: Comparison of Selected Reaction Monitoring with Full Scan MS/MS for Amphetamines, Opiates and Cocaine Metabolite
Robert Fitzgerald
VA San Diego/UCSD

Confirmed
A Reference Measurement Procedure to Quantify Urinary Albumin
Ashley S. Beasley
National Institute of Standards and Technology

Confirmed
Proteomic Identification of Coccidioidal Antigens from Lung Fluid of Infected Mice: MRM Analysis to Confirm Presence in Biological Fluids
Forrest S.E. Helfrich
University of Arizona

Confirmed
10:00 AM COFFEE BREAK
Biomarkers in Drug Discovery:
Future Companion Diagnostic Assays

Chair: Mike Greig

Track 1

Microbes and Infectious Disease
Chair: Richard Ill


Track 2

Tobacco Exposure
Chair: Tom Bernert



Track 3

10:30 AM Personalized Medicine of Thiopurine Therapy in Autoimmune Diseases: Contribution of LC-MS/MS Analysis
Thierry Dervieux
Exagen Diagnostics

Confirmed
Comparative Analysis of PCR Electrospray Ionization Mass Spectrometry to MALDI-ToF Mass Spectrometry for the Identification of Bacteria and Yeast from Positive Blood Culture Bottles
Erin J. Kaleta
University of Arizona

Confirmed
Tobacco Biomarker Measurements by Tandem Mass Spectrometry - Population Exposure Estimates in National Surveys
Tom Bernert
CDC

Confirmed
11:00 AM Protein Biomarker LC-MS/MS Assays in Translational Pharmacology- from Early Discovery to Proof-of-Concept Clinical Trials
Hendrik Neubert
Pfizer

Confirmed
Masscode Pathogen Detection Platform
Craig Monell
Agilent Technologies

Confirmed
Toenail And Hair Nicotine Biomarkers Research Applications
Wael K. Al-Delaimy
University of California, San Diego

Confirmed
11:30 AM Glycan Markers for Disease Diagnosis
Carlito Lebrilla
University of California, Davis

Confirmed
Strain Identification of Methicillin-Sensitive Staphylococcus Aureus from a Neonatal Intensive Care Unit using MALDI-ToF Mass Spectrometry
Richard R. Drake
Eastern Virginia Medical School

Confirmed
Mass Spectrometric Methods for Studies of Nicotine Metabolism and Tobacco Carcinogen Exposure - Some Recent Applications in Clinical Research
Peyton Jacob
University of California, San Francisco

Confirmed
12:00 PM The Impact of Chromatography and High Resolution Mass Spectrometry for Targeted and Non-Targeted Data Analysis
Timothy Croley
US Food and Drug Administration

Confirmed
Identification of Microorganisms by MALDI-TOF MS Profiling
Markus Kostrzewa
Bruker Daltonik GmbH

Confirmed
Biomarkers of Tobacco Smoking-induced Oxidative Stress
Ian Blair
University of Pennsylvania

Confirmed
12:30 PM LUNCH (provided)
Sample Preparation and Automation Strategies
Chair: Russell Grant

Track 1

Discovery Metabolomics
Chair: Matthew Greving


Track 2

Proficiency Testing
Chair: Robert Kobelski


Track 3

2:00 PM Errors in Bioanalysis Due to Phospholipids - Definitive Measurement, Mechanism, and Management
Brian Rappold
LabCorp

Confirmed
Metabolomics of Plasma Reveal Novel Endogenous Metabolites Involved in Coagulation
Sunia Trauger
The Scripps Research Institute

Confirmed
The Landscape of Mass Spectrometry in the Clinical Laboratory
Jerry Thomas
CDC/NCEH

Confirmed
2:30 PM High-Throughput Automated System for SISCAPA Sample Preparation for Clinical Proteomics
Matthew Rosenow
Translational Genomics Research Institute

Confirmed
Metabolic Predictors of Insulin Sensitivity Predict Progression to Impaired Glucose Tolerance
Walter Gall
Metabolon

Confirmed
What Goes on Behind the Scenes in CAP Proficiency Testing?
Gary Horowitz
Beth Israel Deaconess Medical Center

Confirmed
3:00 PM The Filter Paper Matrix: The New Frontier of Blood Lead Screening Kansas Department of Health and Environmental Laboratories
Jon Brady
Kansas Department of Health and Environmental Laboratories

Confirmed
Evaluating the Intestinal Health of Infants by Analysis of Excreted Oligosaccharides
Maria Lorna A. De Leoz
University of California, Davis

Confirmed
Proficiency Testing: Nuisance, Regulatory Requirement, or Critical Tool?
Robert Kobelski
CDC

Confirmed
3:30 PM A Comparison of Immobilized Liquids Used for Sample Clean-up Prior to LC/MS Analysis of Antidepressants and Active Metabolites
Rob Wohleb
ILE, Inc.

Confirmed
High Throughput and Standardized LC-MS/MS Steroid-Quantification for Clinical Metabolomics
Therese Koal
Biocrates Life Sciences, AG

Confirmed
Proficiency Testing (PT) as a Quality Tool: Values and Limitations
Noel Stanton
Wisconsin State Laboratory of Hygiene

Confirmed
4 - 8 PM Hospitality Suite Closing Reception
Outdoor Heated Patio Overlooking San Diego Marina
Buffet Dinner

Poster Presentations

POSTERS: Monday Feb 7
Exhibit Hall: Attended from 2:00-3:00 PM
Includes All PosterSplashes Presented from the Podium Between 12:00-12:30PM
31. Metabolic Ratios of Excreted Pain Medications Obtained by LC-MS/MS Analysis can be used to Determine Aberrant Drug Metabolism
Amadeo Pesce
Millennium Laboratories

Confirmed
33. Using Exactive Mass Spectrometry for Comprehensive Medication Screening to Monitor Polypharmacy in the Pain Management Population
Bridgit Crews
Millennium Research Institute

Confirmed
35. Use of a Dual Liquid Chromatography-Mass Spectrometry Method for Screening and Confirmatory Testing of Drugs of Abuse in an Urban HIV-Positive Emergency Room Population
Autumn Breaud
The Johns Hopkins University

Confirmed
37. A Fully Automated Turbulent Flow Liquid Chromatography Isotope Dilution Mass Spectrometry (LC-IDMS) Method for Quantitation of Voriconazole in Human Serum
Robert Harlan
Johns Hopkins University

Confirmed
39. Clinical Validation of a Multiplexed EGFR Signaling Pathway Assay in FFPE Colorectal Cancer Tissue
Todd Hembrough
Expression Pathology, Inc.

Confirmed
41. Ultra-fast, Simultaneous Analysis of a Panel of Benzodiazepines in Human Urine Using an SPE-TOF System
Vaughn Miller
BIOCIUS Life Sciences

Confirmed
43. Fast and Sensitive Amino Acid Analysis using aTRAQ Derivatization and UPLC-MS/MS
Brent Dawson
AB SCIEX

Confirmed
45. Efficient and Sensitive Analysis of THC in Oral Fluid by LC-MS/MS Utilizing CEDIA® THC OFT Test Kit
Kristine Van Natta
ThermoFisher Scientific

Confirmed
47. The Effect of Mass Spectrometric Variance of Busulfan Concentration Measurement on the Pharmacokinetic Area Under the Curve: Analytical Variance with Clinical Implications
Matthew T. Olson
Johns Hopkins Hospital

Confirmed
49. Extraction of Tamoxifen and Metabolites from Urine and Plasma using Supported Liquid Extraction (SLE) prior to UPLC-MS/MS Analysis
Lee Williams
Biotage GB Limited

Confirmed
51. Vitamin D and Metabolites: Evaluation of Supported Liquid Extraction (SLE) Prior to UPLC-MS/MS Analysis
Lee Williams
Biotage GB Limited

Confirmed
53. Field Flow Fraction Separation and On-Line Mass Spectrometric Detection of Organelles from Heart Cells
Dale Chatfield
San Diego State University

Confirmed
55. Rapid Protein Extraction and Trypsin Digestion with Pressure Cycling Technology (PCT)
Paul H Pevsner
University of Missouri School of Medicine

Confirmed
57. Sensitive LC-MS/MS Method for Determination of 25-Hydroxyvitamin D3 and its C3-Epimer after Diels-Alder Derivatization
Evgueni Fedorov
Warnex Bioanalytical Services

Confirmed
59. A Comparison Study of Semi-Porous and Porous Particles for Fast LC-MS-MS Analysis Using Conventional LC Instrumentation
Rick Link
Supelco/Sigma-Aldrich

Confirmed
61. Toxicological Screening of 80 Drugs in Urine Samples Using the High Resolution Exactive LC/MS Orbitrap Mass Spectrometer Coupled to Online Extraction and Turbulent Flow Chromatography
Touraj Shokati
UC Denver

Confirmed
63. Mutation and Tissue Preferential Accumulation of Glucosylceramides in Gaucher Disease Mouse Model
Wujuan Zhang
Cincinnati Children's Hospital

Confirmed
65. Increased Process Efficiency in UPLC-MS/MS Data Review Through Use of Rules-Based Software Automation
Joseph Ervin
AIT Laboratories

Confirmed
67. Use of Waters Systematic Toxicology Analysis with Chromalynx in the Hospital Laboratory
John Shepherd
Hull Royal Infirmary

Confirmed
69. Observations on the Metabolism of Morphine to Hydromorphone in Pain Patient Urinary Excretion Data using LC-MS/MS
Michelle Hughes
University of California, San Diego

Confirmed
71. Determination of Conjugated and Unconjugated Tapentadol (Nucynta®) and N-Desmethyltapentadol in Authentic Urine Specimens by UPLC/MS/MS
James Bourland
Ameritox

Confirmed
73. An LC-MS/MS Analytical Method for Barbiturate Analysis in Urine
Theresa Lee
AB SCIEX

Confirmed
75. An LC-MS/MS Analytical Method for Pregabalin and Tapentadol Analysis in Urine and Plasma
Theresa Lee
AB SCIEX

Confirmed
77. Urine and Saliva Cortisol Measurement by LC-MS/MS
Hendrick E van Deventer
NIH Clinical Center

Confirmed
79. Molecular Weight Exclusion of Proteins Using Turbulent Flow Chromatography
Joseph Herman
ThermoFisher

Confirmed
Exhibit Hall: Attended from 6:30-7:30 PM
Includes All PosterSplashes Presented from the Podium Between 4:30-5:00PM
32. Increasing Throughput by Multiplexing Drugs of Abuse Analysis
Michael Jarvis
AB SCIEX

Confirmed
34. Recent Advances in Measuring VOCs in Blood as Biomarkers of Exposure
Ben Blount
CDC

Confirmed
36. Transfer of 25-Hydroxyvitamin D2/D3 Analysis in Human Plasma to Core-Shell Columns to Improve Sample Throughput in a Clinical Laboratory
Philip J. Koerner
Phenomenex

Confirmed
38. A Simplified and Streamlined Approach to Solid Phase Extraction for the New SAMHSA Drugs of Abuse Panel
Michael Rummel
Phenomenex

Confirmed
40.

42. Development of a Mass Spectrometry Method to Identify Specific Peptides of a Novel Prostate Cancer Associated Retrovirus
Jeanne Rhea
Emory University

Confirmed
44. Confirmatory Quanitation of Benzodiazepines in Post-Mortem Matrices using HPLC/MS with Online Sample Preparation
Kathryn Preston
Thermo Fisher Scientific

Confirmed
46. Rapid Extraction of Four Immunosuppressants from Blood for Sequential Sample Preparation Prior LC-MS/MS Analysis
Michael Vogeser
Hospital of the University of Munich

Confirmed
48. LC-MS/MS and GC-MS methods for Phthalates and Bisphenol-A
William Ofsa
NMS Labs

Confirmed
50.

52. 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Analysis Using a QTRAP® 5500 Tandem Mass Spectrometer and the MPX™-2 High Throughput Multiplexed HPLC System
Jesse C. Seegmiller
AB SCIEX

Confirmed
54. MALDI and LCMS Identifications of Protein and ICP-MS Identification of Metal Biomarkers of Ionizing Radiation
Paul H Pevsner
University of Missouri School of Medicine

Confirmed
56. Benign vs. Malignant Colorectal Polyps-Mass Spectrometry Diagnosis
Paul H Pevsner
University of Missouri School of Medicine

Confirmed
58. Using 200 µm ID cHiPLC Columns for Increased Sample Throughput in Peptide Quantitation
Nicole Hebert
Eksigent Technologies

Confirmed
60. Metlin: A Mass Spectrometry Web Database Application for Metabolite Characterization in Global Unbiased Metabolomics
Kevin Y. Cho
The Scripps Research Institute

Confirmed
62. A Liquid Chromatography Tandem Mass Spectrometry-Based Method for Analysis of Total Testosterone in Human Serum
Michael Jarvis
AB SCIEX

Confirmed
64. Development of a Simple and Fast Method for the Measurement by LC-MS/MS of Salivary Cortisol, Androstenedione and Testosterone
Bruno Casetta
AB SCIEX

Confirmed
66. Tranexamic Acid Quantitation in Cardiopulmonary Bypass Patients Using Ultra Performance LC-MS/MS
Ross Molinaro
Emory University

Confirmed
68. Neonatal Screening Test for Inherited Metabolic Disorders by Tandem Mass Spectrometry in Korea; Experience of the Eone Reference Laboratory for 3 years
Cho Sung Eun
Eone Reference Laboratory

Confirmed
70. A Streamlined Method for Methylmalonic Acid (MMA) Quantitation in Serum using Automated Supported Liquid Extraction and LC-MS/MS
Julia C. Drees
Kaiser Permanente Regional Laboratories

Confirmed
72.

74. Validation of Immunosuppressant Calibrator and QC Reagents Using On-Line Extraction Coupled to LC-MS/MS
Laura Bechtel
Memorial Sloan Kettering Cancer Center

Confirmed
76. Measurement of Urine Orotic Acid and Orotidine by UPLC-MS/MS
Lis Schwarz
ARUP Laboratories, Inc

Confirmed
78. Mapping of Signaling Molecules within Biofilms in a System-Wide Fashion
Jessica Karr
UCSD

Confirmed
80. Challenges in Analysis of Testosterone/Epitestosterone in Urine by LC-MS/MS
Koyuki Takenaka
San Diego State University

Confirmed

POSTERS: Tuesday Feb 8
Exhibit Hall: Attended from 2:00-3:00 PM
Includes All PosterSplashes Presented from the Podium Between 12:00-12:30PM
31. LC-MS/MS Analysis of Buprenorphine and its Metabolites in Urine and the Importance of Norbuprenorphine Cross-Reactivity in an Immunoassay Screen
Christine Moore
Immunalysis Corporation

Confirmed
33. UPLC-MS/MS Measurements of 25(OH) Vitamin D2 and 25(OH) Vitamin D3 in the Pediatric Population in Atlanta, GA at Latitude 33° North
Charbel Abou Diwan
Emory University

Confirmed
35. A Simple and Fast Method for the Analysis of Water and Fat Soluble Vitamins in Cell Culture Media using HPLC-ESI-MS/MS
Diane Schmiederer
Biocrates Life Sciences AG

Confirmed
37. SRM-based LC-MS Method for Detection of Hemoglobin Variants at Hemoglobinopathies Diagnostics
Oksana Gvozdyak
ThermoFisher Scientific

Confirmed
39. Toxicology: A Targeted LC-MS/MS Approach to a Rapid & Comprehensive Pain Management Analysis
Peter Stone
Agilent Technologies, Inc.

Confirmed
41. Multifunctional Core-Shell Nanoparticles Provide a One-Step Solution for the Identification of Elusive Low-Abundance Clinical Biomarkers
Benjamin Lepene
Ceres Nanosciences

Confirmed
43. Unraveling Mixture Toxicity in Human Populations: Towards Standardized Umbilical Cord Blood Proteomics
Nicole Hansmeier
The Biodesign Institute at Arizona State University

Confirmed
45. Detection of Levamisole Exposure in Cocaine Users by LC-MS/MS
Kara L. Lynch
University of California, San Francisco

Confirmed
47. Development of a Candidate Reference Measurement Procedure for Determination of Phenytoin, Phenobarbital, Lamotrigine, and Topiramate in Human Serum Using Isotope-Dilution LC-MS/MS
Susan Tai
National Institute of Standards and Technology

Confirmed
49. Measuring Busulfan in Blood Plasma Using On-Line Extraction Coupled to LC-MS/MS by APCI and HESI
Ryan C. Schofield
Memorial Sloan-Kettering Cancer Center

Confirmed
51. Reducing the Need for Technical Replicates - Implementation of Peptide QC Standards
Scott Peterman
ThermoFisher Scientific

Confirmed
53. Analysis of Cortisol, Cortisone and Dexamethasone in Serum Using LC-MS/MS and Assessment of Cortisol: Cortisone Ratios in Patients with Impaired Kidney Function
Julie A. Ray
ARUP Laboratories

Confirmed
55. A Fast, Simple Method for the Analysis of Pain Management Drugs in Human Urine Utilizing LC-MS/MS
John McFarlane
AB SCIEX

Confirmed
57. Detection of Age-Related Histone PTMs as M/Z Pair Tags in LC-MS Measurement of Mesenchymal Stem Cell Lysates
Michael Athanas
Vast Scientific

Confirmed
59. Disulfide Mapping Verification using SIEVE
Michael Athanas
Vast Scientific

Confirmed
61. The Measurement of Free Thyroxine (T4) and Triiodothyronine (T3) Using a QTRAP®5500 LC/MS/MS System
Brent Dawson
AB Sciex

Confirmed
63. Solvent Dependent Variability in Vitamin D Analysis
Eduard Rogatsky
Albert Einstein College of Medicine

Confirmed
65. Rapid Detection of Resistance Against ß-lactam Antibiotics by MALDI-TOF MS
Markus Kostrzewa
Bruker Daltonik GmbH

Confirmed
67. Using In Vitro Model to Aid the Identification and Screening of Major Metabolites of K2 in Human Urine
Brent Dawson
AB Sciex

Confirmed
69.

71. Quantification of Digoxin and its Metabolite Dihydrodigoxin by Mass Spectrometry and Implications for Cancer Therapeutics
Steven M. Truscott
University of Louisville

Confirmed
73. Analytical Performance of Mass Trak Kit for Tacrolimus and Cyclosporine Assay by LC-MS/MS
Yeo Min Yun
Konkuk University Hospital and School of Medicine

Confirmed
75. Development of Targeted Screening Method for Drug of Abuse Using Ultraperformance LC-MS/MS
Yeo Min Yun
Konkuk University Hospital and School of Medicine

Confirmed
77. A High-throughput LC-MS Assay for Drugs of Abuse in Urine
Jan Palaty
LifeLabs Medical Laboratories

Confirmed
79. Identification of Proteins in Plasma of Lung Cancer Patients and Control Groups Using the Combined LC-ESI-MS/MS Approach
WITHDRAWN

Valery Shevchenko
N. N. Blokhin Russian Cancer Research Center
Exhibit Hall: Attended from 6:30-7:30 PM
Includes All PosterSplashes Presented from the Podium Between 4:30-5:00PM
32. Intact and Functional Mitochondria from Solid Tissue: Effective Semi-Automated Extraction Using Gentle Mechanical Homogenization and Pressure Cycling Technology
Vera Gross
Pressure Biosciences, Inc.

Confirmed
34. An LC-MS/MS Method for Simultaneous Analysis of Cyclosporin A and Tacrolimus in a Transplant Population and Comparison with the Abbott IMx and AxSYM, Respectively
Marguerite MacMahon
Mater Misericordiae University Hospital
36. Efficient Identification of Statistically Significant Protein Biomarker Candidate Panels by Generation of Multi-Marker ROC Curves
Amol Prakash
ThermoFisher Scientific

Confirmed
38. Anabolic Androgenic Steroid Testing by Liquid Chromatography Quadrupole Time-Of-Flight Mass Spectrometry in Urine
Erica Angelique Guice
Western Slope Laboratory, LLC

Confirmed
40. LC-MS/MS Method for the Measurement of Serum Mevalonic Acid: A Novel Marker of HMG-CoA Reductase Inhibition by Statins
Jenna Waldron
Heart of England NHS Foundation Trust

Confirmed
42. Multimode, Single-Shot Mass Spectrometry with Nanomechanical Devices
Mehmet Selim Hanay
California Institute of Technology

Confirmed
44. MALDI Mass Spectrometry with a Nanomechanical Resonator for Direct Mass Measurement of Neutral and Ionized Bioparticles
Scott Kelber
CalTech

Confirmed
46. Generic LC-MS Method for Quantitative Analysis of Drugs in Human Urine Implementing Ultra-High Resolution Mass Spectrometer Exactive(TM)
Marta Kozak
Thermo Scientific

Confirmed
48. UPLC-MS/MS Simultaneous Determination of Cocaine Metabolites and its Adulterant Levamisole in Urine
Charbel Abou Diwan
Emory University
50. A Simplified Workflow for the Analysis of 25-Hydroxyvitamin D3 and 25-Hydroxyvitamin D2 using Commercially Available Plasma Calibrators and Controls and LC-MS/MS
Michael Jarvis
AB SCIEX

Confirmed
52.

54. Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Two Korean Patients: Case Reports and Identification of a Novel ACADM Mutation
Yong-Wha Lee
Soonchunhyang University

Confirmed
56. Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for Endopeptidase Activity Based Quantification of Anthrax Lethal Factor in Serum
Zsuzsanna Kuklenyik
CDC

Confirmed
58. Selective Capture and Biosensing with Gold Nanorod Supported Lipid Bilayers
Edward T. Castellana
Texas A&M University

Confirmed
60. Calcium Metabolism in Castration-Resistant Prostate Cancer Patients: Development of a Quantitative Urinary Assay for Extent of Bone Metastasis
Darren Hillegonds
Lawrence Livermore Nat'l Lab

Confirmed
62. Quantitation of Benzodiazepines, Opiates, Amphetamines and Recreational Drugs (B.O.A.R.D panel)in Urine by LC-MS/MS
Susan C. Leonard
AB Sciex

Confirmed
64. Evaluating the Relationship of Carisoprodol Concentrations and Meprobamate Formation in Pain Patients
Stephanie Tse
University of California, San Diego

Confirmed
66. Direct and Fast Identification of Bacteria from Positively Flagged Blood Cultures Using MALDI-TOF MS
Markus Kostrzewa
Bruker Daltonik GmbH

Confirmed
68. Automated Solid Phase Extraction of Plasma Metanephrine, Normetanephrine and 3-Methoxytyramine for Analysis by LC-MS/MS
Lisa Calton
Waters Corporation

Confirmed
70. Analysis of Fentanyl and Its Metabolites in Human Urine with Ultra-High Resolution Exactive Benchtop Mass Spectrometer Coupled to High Performance Liquid Chromatography
Xiang He
ThermoFisher Scientific

Confirmed
72. Validation of SAMHSA Guideline Compliant LC-MS Method for the Newly Expanded NIDA 5 Panel Using Ultra-High Resolution Accurate Mass Exactive Mass Spectrometer
Xiang He
ThermoFisher Scientific

Confirmed
74. Analysis of Phthalate Metabolites in Human Urine, MARBLES Study
Rana Zahedi
California Department of Public Health

Confirmed
76. A Pilot Study on the Determination of Persistent Organic Pollutants in Dried Blood Spots from Newborn Screening Program of New York State
Chunyang Liao
State University of New York at Albany

Confirmed
78. Improved Sensitivity and Speed of Fatty Acid Analysis by Orbitrap Mass Spectrometry from any Biological Matrix
Xingnan Li
Cancer Research Center of Hawaii

Confirmed
80. Urinary Protein Profiles in Healthy Individuals, Patients with Proteinuria and Histoplasma Antigenuria
Mark Kushnir
ARUP Institute for Clinical and Experimental Pathology

Confirmed

Exhibits

Exhibit Hall Hours

Sun 3:00-7:30 PM Reception
Mon 12:30-3:00 PM Lunch
Mon 5:00-7:30 PM Reception
Tue 12:30-3:00 PM Lunch
Tue 5:00-7:30 PM Reception

Golden West Biologicals
Booth A
MicroLiter Analytical Supplies
Booth B
Nonlinear Dynamics
Booth C
Geneva Bioinformatics (GeneBio)
Booth D
Biotage
Booth 1
Imtakt
Booth 2
Shimadzu Scientific Instruments
Booth 3
Metabolon
Booth 4
Parker Hannifin
Booth 5
TBA
Booth 6
SP Scientific
Booth 7
Pressure BioSciences
Booth 8
IONICS Mass Spectrometry Group
Booth 9
Tecan
Booth 10
Agilent Technologies
Booth 11
Peak Scientific Instruments
Booth 12
Abbott
Booth 13
PerkinElmer
Booth 14
Chromsystems
Booth 15
AB Sciex
Booth 16
Cambridge Isotope Labs
Booth 17
Biocius Life Sciences
Booth 18
Indigo Biosystems
Booth 19
Waters
Booth 20
BIOCRATES Life Sciences
Booth 21
IsoSciences
Booth 22
Thermo Scientific
Booth 23
Thermo Scientific
Booth 24
Cerilliant
Booth 25
Phenomenex
Booth 26
Bruker Daltonics
Booth 27
Michrom Bioresources
Booth 28

Exhibit Hall Diagram